Latest Cetuximab Stories
Scientists have found a new way to heighten or restore the potency of a widely-used cancer drug.
Scientists at Dana-Farber Cancer Institute and colleagues overseas have discovered a pair of backup circuits in cancer cells that enable the cells to dodge the effect of a widely used cancer drug.
GERMANTOWN, Maryland and HILDEN, Germany, August 5, 2011 /PRNewswire/ -- ? - Food and Drug Administration will review therascreen(R) KRAS RGQ PCR Kit for use with Erbitux(R) (cetuximab), a metastatic colorectal cancer therapy - PMA follows a recent submission for use with another EGFR inhibitor drug, also in patients with metastatic colorectal cancer - QIAGEN achieves milestones in Personalized Healthcare with...
QUEBEC CITY, July 27, 2011 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:Â AEZ) (the "Company") today announced the completion of patient recruitment for the ongoing Phase 3 trial with perifosine in refractory advanced colorectal cancer.